This year’s symposium will concentrate on moving stem cells into therapies for pediatric neurodegenerative diseases. An international slate of speakers will discuss pediatric neurodegenerative diseases, stem cell sources and properties, treatment of experimental models of neurodegenerative disease with stem cells, immune system rejection of stem cells, and current clinical trials of stem cells in pediatric neurodegenerative diseases.
REGISTRATION:
Registration is closed. There will be no on-site registration.
LOCATION:
The symposium is being held in the Harold Wade Conference Center, 2nd floor CHOC West Building, Children's Hospital of Orange County, 455 South Main Street, Orange, California. Parking is best reached from Providence Street, off of Main Street. See map.
SCHEDULE:
7:30 am - Breakfast
8:00 am - Morning session of speakers
12:45pm - Lunch
2:00 pm - Afternoon session of speakers
5:00 pm - Panel discussion
6:00 pm - Reception
6:30 pm – Dinner
PROGRAM MODERATORS:
Jeanne Loring, PhD
Director, Center for Regenerative Medicine, The Scripps Research Institute
Philip Schwartz, PhD
Director, CHOC Human Neural Stem Cell Resource, CHOC Research Institute
SPEAKERS:
Theo Palmer, PhD
Associate Professor of Neurosurgery, Stanford University School of Medicine
Brain-derived NSCs for transplantation
Su-Chun Zhang, PhD
Associate Professor, Stem Cell Research Program, University of Wisconsin Madison
ESC-derived NSCs for transplantation
Donald Phinney, PhD
Associate Professor, Center for Gene Therapy, Tulane University Health Science Center
MSCs for transplantation
Lisa Flanagan, PhD
UC Irvine
Sorting stem cell subpopulations
Paul Fairchild, DPhil
RCUK Academic Fellow, Sir William Dunn School of Pathology, University of Oxford
Immunology of stem cell transplantation
Jose Abdenur, MD
Medical Director, Metabolic Disorders, Children’s Hospital of Orange County
LSDs and their current therapies
Paul Orchard, MD
Medical Director, Inherited Metabolic and Storage Disease Bone Marrow Transplantation Program, University of Minnesota Children’s Hospital
BMT for the LSD
Joanne Kurtzberg, MD
Chief, Division of Pediatric Blood and Marrow Transplantation,
Duke University
Neonatal UCB transplant for the LSDs
Patricia Dickson, MD
UCLA
Intrathecal enzyme delivery for the LSDs
Philip Schwartz, PhD
Director, CHOC Human Neural Stem Cell Resource, CHOC Research Institute
NSC neurotherapy in the LSDs
Donald Phinney, PhD
Associate Professor, Center for Gene Therapy, Tulane University Health Science Center
MSC neurotherapy in the LSDs
Stephen Back, MD, PhD
Director, Pediatric Brain Injury Research Laboratory, Doernbecher Children’s Hospital
Brain barriers to stem cell neurotherapy
Stephen Huhn, MD
Vice President (Neural Program), StemCells, Inc.
NSC neurotherapy in NCL patients
SPONSORS:
|
